Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
vitamin d3 (1 trial)
Galactose (1 trial)
Congenital Abnormalities (Phase 2)
Heart Defects, Congenital (Phase 2)
Vitamin D Deficiency (Phase 2)
Trials (2 total)
Trial APIs (2 total)